These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

411 related items for PubMed ID: 1412164

  • 1. Depression of tissue-type plasminogen activator and enhancement of urokinase-type plasminogen activator as an expression of local inflammation.
    Brommer EJ, Dooijewaard G, Dijkmans BA, Breedveld FC.
    Thromb Haemost; 1992 Aug 03; 68(2):180-4. PubMed ID: 1412164
    [Abstract] [Full Text] [Related]

  • 2. Peritoneal fluid and plasma fibrinolytic activity in women with pelvic inflammatory disease.
    Dörr PJ, Brommer EJ, Dooijewaard G, Vemer HM.
    Thromb Haemost; 1992 Aug 03; 68(2):102-5. PubMed ID: 1412151
    [Abstract] [Full Text] [Related]

  • 3. Interaction between plasminogen activator inhibitor type 1 (PAI-1) bound to fibrin and either tissue-type plasminogen activator (t-PA) or urokinase-type plasminogen activator (u-PA). Binding of t-PA/PAI-1 complexes to fibrin mediated by both the finger and the kringle-2 domain of t-PA.
    Wagner OF, de Vries C, Hohmann C, Veerman H, Pannekoek H.
    J Clin Invest; 1989 Aug 03; 84(2):647-55. PubMed ID: 2503541
    [Abstract] [Full Text] [Related]

  • 4. Post-traumatic plasminogenesis in intraarticular exudate in the knee joint.
    Rość D, Powierza W, Zastawna E, Drewniak W, Michalski A, Kotschy M.
    Med Sci Monit; 2002 May 03; 8(5):CR371-8. PubMed ID: 12011780
    [Abstract] [Full Text] [Related]

  • 5. Plasminogen activators t-PA, u-PA and its inhibitor (PAI) in normal males and females.
    Koh SC, Yuen R, Viegas OA, Chua SE, Ng BL, Sen DK, Ratnam SS.
    Thromb Haemost; 1991 Nov 01; 66(5):581-5. PubMed ID: 1803623
    [Abstract] [Full Text] [Related]

  • 6. Hyaluronic acid inhibits the expression of u-PA, PAI-1, and u-PAR in human synovial fibroblasts of osteoarthritis and rheumatoid arthritis.
    Nonaka T, Kikuchi H, Ikeda T, Okamoto Y, Hamanishi C, Tanaka S.
    J Rheumatol; 2000 Apr 01; 27(4):997-1004. PubMed ID: 10782829
    [Abstract] [Full Text] [Related]

  • 7. Plasminogen activators (t-PA and u-PA) and plasminogen activators inhibitors (PAI-1 and PAI-2) in some myeloproliferative syndromes.
    Rość D, Kremplewska-Nalezyta E, Gadomska G, Zastawna E, Michalski A, Drewniak W.
    Med Sci Monit; 2000 Apr 01; 6(4):684-91. PubMed ID: 11208392
    [Abstract] [Full Text] [Related]

  • 8. A sensitive bioimmunoassay for thrombin-cleaved two-chain urokinase-type plasminogen activator in human body fluids.
    Braat EA, Nauland U, Dooijewaard G, Rijken DC.
    Thromb Haemost; 1996 Jun 01; 75(6):908-14. PubMed ID: 8822585
    [Abstract] [Full Text] [Related]

  • 9. Fibrinolysis and coagulation in patients with infectious disease and sepsis.
    Philippé J, Offner F, Declerck PJ, Leroux-Roels G, Vogelaers D, Baele G, Collen D.
    Thromb Haemost; 1991 Mar 04; 65(3):291-5. PubMed ID: 1904655
    [Abstract] [Full Text] [Related]

  • 10. Absence of synergism between tissue-type plasminogen activator (t-PA), single-chain urokinase-type plasminogen activator (scu-PA) and urokinase on clot lysis in a plasma milieu in vitro.
    Collen D, De Cock F, Demarsin E, Lijnen HR, Stump DC.
    Thromb Haemost; 1986 Aug 20; 56(1):35-9. PubMed ID: 3095946
    [Abstract] [Full Text] [Related]

  • 11. Plasminogen activator inhibitors type 1 and type 2 and plasminogen activators in amniotic fluid during pregnancy.
    Estellés A, Gilabert J, Andrés C, España F, Aznar J.
    Thromb Haemost; 1990 Oct 22; 64(2):281-5. PubMed ID: 2125378
    [Abstract] [Full Text] [Related]

  • 12. Evolution of urokinase-type plasminogen activator (u-PA) and tissue-type plasminogen activator (t-PA) in orthotopic liver transplantation (OLT).
    Himmelreich G, Dooijewaard G, Breinl P, Bechstein WO, Neuhaus P, Kluft C, Riess H.
    Thromb Haemost; 1993 Jan 11; 69(1):56-9. PubMed ID: 8446939
    [Abstract] [Full Text] [Related]

  • 13. Control of the chondrocyte fibrinolytic balance by the drug piroxicam: relevance to the osteoarthritic process.
    Fibbi G, Serni U, Matucci A, Mannoni A, Pucci M, Anichini E, Del Rosso M.
    J Rheumatol; 1994 Dec 11; 21(12):2322-8. PubMed ID: 7699636
    [Abstract] [Full Text] [Related]

  • 14. Selected parameters of fibrinolysis system in patients with dermatitis herpetiformis.
    Wankiewicz A, Iwan-Zietek I, Kotschy M, Gwieździński Z.
    Med Sci Monit; 2002 Mar 11; 8(3):CR189-92. PubMed ID: 11887034
    [Abstract] [Full Text] [Related]

  • 15. Urokinase-type plasminogen activator, receptor, and inhibitor correlating with gelatinase-B (MMP-9) contribute to inflammation in gouty arthritis of the knee.
    Chu SC, Yang SF, Lue KH, Hsieh YS, Hsiao TY, Lu KH.
    J Rheumatol; 2006 Feb 11; 33(2):311-7. PubMed ID: 16465663
    [Abstract] [Full Text] [Related]

  • 16. The fibrinolytic system in neoplasia.
    Bell WR.
    Semin Thromb Hemost; 1996 Feb 11; 22(6):459-78. PubMed ID: 9122711
    [Abstract] [Full Text] [Related]

  • 17. Plasminogen activators and plasminogen activator inhibitors in liver deficiencies caused by chronic alcoholism or infectious hepatitis.
    Tran-Thang C, Fasel-Felley J, Pralong G, Hofstetter JR, Bachmann F, Kruithof EK.
    Thromb Haemost; 1989 Sep 29; 62(2):651-3. PubMed ID: 2510345
    [Abstract] [Full Text] [Related]

  • 18. Urokinase-mediated fibrinolysis in the synovial fluid of rheumatoid arthritis patients may be affected by the inactivation of single chain urokinase type plasminogen activator by thrombin.
    Braat EA, Jie AF, Ronday HK, Beekman B, Rijken DC.
    Ann Rheum Dis; 2000 Apr 29; 59(4):315-8. PubMed ID: 10733483
    [Abstract] [Full Text] [Related]

  • 19. Fibrinolysis in normal subjects--comparison between plasminogen activator inhibitor and other components of the fibrinolytic system.
    Nicoloso G, Hauert J, Kruithof EK, Van Melle G, Bachmann F.
    Thromb Haemost; 1988 Apr 08; 59(2):299-303. PubMed ID: 3133812
    [Abstract] [Full Text] [Related]

  • 20. Plasminogen-dependent and -independent proteolytic activity of murine endothelioma cells with targeted inactivation of fibrinolytic genes.
    Lijnen HR, Wagner EF, Collen D.
    Thromb Haemost; 1997 Feb 08; 77(2):362-7. PubMed ID: 9157597
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.